Hospital at Home at EOL in Heme Malignancies

Completed · Not applicable

Conditions studied: Hematologic Malignancy

In brief

This study is evaluating an intervention, which the investigators call "Optimize End of Life (EOL) Care at Home," that entails remote patient monitoring and home-based supportive care for patients with advanced hematologic malignancies.

Key facts

Study ID

NCT04690205

Run by

Massachusetts General Hospital

People needed

72

Starts

2021-02-26

Expected to finish

2025-07-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 or older
• diagnosed with relapsed or refractory hematologic malignancy
• must be receiving treatment with non-curative intent or supportive care alone based on the intent of chemotherapy as reported in order entry or Electronic Health Record
• deemed eligible to receive EOL care at home based on the primary oncologist's assessment
• Able to communicate and respond to questionnaires in English or with the assistance of an interpreter.
• residing within 50 miles of MGH. Of note, patients requiring supportive transfusions in the oncology clinic will still be eligible to participate.

You may not qualify if…

• Those with uncontrolled psychiatric illness or impaired cognition interfering with their ability to understand study procedures and provide written informed consent as determined by the primary oncologist.

Where it is running

• Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.